Prediction of binding modes for ligands in the cytochromes p450 and other heme-containing proteins

被引:90
作者
Kirton, SB [1 ]
Murray, CW [1 ]
Verdonk, ML [1 ]
Taylor, RD [1 ]
机构
[1] Astex Technol, Cambridge CB4 0QA, England
关键词
docking; scoring functions; cytochrome P450; heme proteins;
D O I
10.1002/prot.20389
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cytochromes P450 (P450s) are a family of heme-containing monooxygenase enzymes involved in a variety of functions, including the metabolism of endogenous and exogenous substances in the human body. During lead optimization, and in drug development, many potential drug candidates are rejected because of the affinity they display for drug-metabolising P450s. Recently, crystal structures of human enzymes involved in drug metabolism have been determined, significantly augmenting the prospect of using structure-based design to modulate the binding and metabolizing properties of compounds against P450 proteins. An important step in the application of structure-based metabolic optimization is the accurate prediction of docking modes in heme binding proteins. In this paper we assess the performance of the docking program GOLD at predicting the binding mode of 45 heme-containing complexes. We achieved success rates of 64% and 57% for Chemscore and Goldscore respectively; these success rates are significantly lower than the value of 79% observed with both scoring functions for the full GOLD validation set. Re-parameterization of metal-acceptor interactions and lipophilicity of planar nitrogen atoms in the scoring functions resulted in a significant increase in the percentage of successful dockings against the heme binding proteins (Chemscore 73%, Goldscore 65%). The modified scoring functions will be useful in docking applications on P450 enzymes and other heme binding proteins. (C) 2005 Wiley-Liss, Inc.
引用
收藏
页码:836 / 844
页数:9
相关论文
共 61 条
[1]   Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].
Aithal, GP ;
Day, CP ;
Kesteven, PJL ;
Daly, AK .
LANCET, 1999, 353 (9154) :717-719
[2]   Applications of the Cambridge Structural Database in organic chemistry and crystal chemistry [J].
Allen, FH ;
Motherwell, WDS .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2002, 58 :407-422
[3]  
Arutyunyan E. G., 1980, KRISTALLOGRAFIYA+, V25, P80
[4]  
Baxter CA, 1998, PROTEINS, V33, P367, DOI 10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.0.CO
[5]  
2-W
[6]  
BELL SG, UNPUB MOL RECOGNITIO
[7]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[8]  
BLACK DJ, WARFARIN FLUCONAZOLE, V2
[9]   Aromatase inhibitors and their application in breast cancer treatment [J].
Brodie, AMH ;
Njar, VCO .
STEROIDS, 2000, 65 (04) :171-179
[10]   New software for searching the Cambridge Structural Database and visualizing crystal structures [J].
Bruno, IJ ;
Cole, JC ;
Edgington, PR ;
Kessler, M ;
Macrae, CF ;
McCabe, P ;
Pearson, J ;
Taylor, R .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2002, 58 :389-397